होम
एक्सप्लोर
nav.journalClub
ट्रेंडिंग
और
synapse
⌘+K
भाषा
हिन्दी
हिन्दी
March 3, 2026
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or Fludrocortisone
CK
Christy Khouderchah
University of Washington
MK
Mehdi Karami
AP
Andrew J. Portuguese
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
See all
Key Points
Idiopathic hypotension occurs in CAR-T therapy patients, leading to significant management challenges.
Key findings indicate that midodrine and fludrocortisone provide symptomatic relief in this population.
Assessment of treatment effects on blood pressure was performed through observational analysis.
Management of hypotension post-CAR-T remains critical; additional validation in larger cohorts is needed.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Khouderchah et al. (Sun,) studied this question.
synapsesocial.com/papers/69a76090c6e9836116a2d6d3
https://doi.org/https://doi.org/10.1016/j.jtct.2025.12.930
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or Fludrocortisone | Synapse